Development of robust gene therapy intellectual property portfolio by Renova Therapeutics for treatm

nDimensionsIP
Jan 7, 2016
1 min read

The biopharmaceutical company has attained an elite worldwide license to several patents from the nonprofit Research Development Foundation (RDF), and the company develops gene therapy treatments for congestive heart failure and other chronic diseases. Along with group of patents, Renova Therapeutics’ has expanded its portfolio in the cardiovascular and metabolic disease space, thus imparting future road for its paracrine gene therapy product pipeline [more]

Recent Posts

See All

General Motors gets Indian patent related to powertrain technology

General Motors has secured an Indian patent on a hybrid powertrain control system for vehicles. The patent rights are currently assigned...

Trademarks Office: Abandonment orders kept in abeyance

Taking into consideration the Delhi High court’s order staying the abandonment orders passed by the Trademarks Office, the Registrar of...

Delhi High Court: No “irreconcilable conflict” between the Competition Act and the Patents Act

The order of the Delhi High Court allows the Competition Commission of India (CCI) to attend to complaints on abuse of dominance of...

nDimensions IP

Development of robust gene therapy intellectual property portfolio by Renova Therapeutics for treatm

Recent Posts

Comments

Working Hours

Contact Us